Upstream process development is a critical component of biologics development, covering the cell culture and bioreactor operations used to generate therapeutic proteins and other biologic products. A well-designed upstream process needs to balance cell growth, product expression, culture stability, process consistency, and product quality while providing a practical basis for scale-up and manufacturing. Protheragen provides Biologics Upstream Process Development services to support the development and optimization of robust mammalian cell culture processes from early development through manufacturing readiness.
Overview of Biologics Upstream Process Development
Biologics upstream process development is the systematic development and optimization of cell culture processes used to produce therapeutic proteins and other biologic products. The process typically begins with evaluating the production cell line and establishing suitable culture conditions, followed by optimization of culture media, feeding strategies, and key bioreactor parameters. Parameters such as temperature, pH, dissolved oxygen, agitation, inoculation density, and culture duration are evaluated to improve cell growth, viability, productivity, and process consistency.
As development progresses, the optimized conditions are transferred to bioreactor systems and evaluated under controlled conditions. Fed-batch or perfusion culture strategies may be developed depending on the characteristics of the cell line, product, and manufacturing objectives. The relationship between upstream process parameters and product quality attributes is also assessed to support process robustness and manufacturing consistency. Finally, the developed process is evaluated for scalability and transferred from laboratory or pilot-scale systems toward larger-scale manufacturing.
Fig.1 Schematic diagram of the CHO perfusion culture for the production of anti-PD-1 monoclonal antibody (mAb). (Liang K, et al., 2023)
Our Services
Protheragen's upstream process development services cover key stages of mammalian cell culture process development, from media screening and culture optimization to bioreactor development and scale-up.
Cell Culture Process Development
We develop and optimize cell culture processes for recombinant proteins, monoclonal antibodies, bispecific antibodies, fusion proteins, and other mammalian cell-based biologics.
Our cell culture development activities include:
Cell culture condition optimization
Inoculation density evaluation
Cell growth and viability optimization
Culture temperature optimization
pH and dissolved oxygen optimization
Agitation and aeration optimization
Culture duration and harvest-time optimization
Metabolite monitoring and control
Cell-specific productivity assessment
Product titer optimization
The development process considers the interaction between cell growth, metabolism, productivity, and product quality to establish culture conditions that provide consistent process performance.
Cell Culture Media Screening and Optimization
Culture media are fundamental to upstream process performance and can significantly affect cell growth, productivity, metabolism, and product quality.
Protheragen supports cell culture media development and optimization through systematic evaluation of basal media, feed media, and selected media components. Depending on project requirements, development activities include:
Basal media screening
Feed media screening
Media formulation optimization
Feed component evaluation
Nutrient concentration optimization
Amino acid and vitamin optimization
Trace element and lipid optimization
Osmolality optimization
Metabolite control
Chemically defined media evaluation
Media and cell line compatibility assessment
Media optimization can be integrated with process parameter studies to identify a suitable combination of media composition and culture conditions.
Feeding Strategy Development
For fed-batch and intensified cell culture processes, feeding strategy is an important determinant of cell growth, metabolic behavior, productivity, and product quality.
Our feeding strategy development services include:
Feed initiation-time optimization
Feed rate optimization
Feed volume and concentration optimization
Intermittent and continuous feeding strategy evaluation
Nutrient consumption analysis
Metabolite-based feeding strategy development
Feed composition optimization
Feeding strategy impact assessment on product quality
The objective is to establish a feeding strategy that supports sustained cell viability and productivity while controlling excessive metabolite accumulation and maintaining the desired product quality profile.
Bioreactor Process Development
Protheragen develops bioreactor-based cell culture processes to translate optimized laboratory conditions into controlled and scalable production processes.
Bioreactor process development may involve the evaluation and optimization of:
Working volume
Inoculation density
Temperature
pH
Dissolved oxygen
Agitation
Aeration
Gas flow
Mixing conditions
Culture duration
Feeding strategy
Harvest conditions
Process parameters are evaluated in relation to cell growth, viable cell density, viability, product titer, metabolite profiles, and relevant quality attributes.
Fed-Batch Process Development
Fed-batch culture is widely used for the production of therapeutic proteins and monoclonal antibodies. Protheragen provides fed-batch process development and optimization to improve culture performance and establish a robust production process.
Development activities include:
Basal and feed media selection
Inoculation strategy optimization
Feed schedule development
Temperature-shift strategy evaluation
pH and dissolved oxygen optimization
Cell growth and productivity assessment
Metabolite monitoring
Harvest-time optimization
Process performance evaluation
The resulting fed-batch process can provide a practical foundation for subsequent process characterization, scale-up, and manufacturing.
Perfusion and Intensified Cell Culture Process Development
For selected biologics programs, perfusion and other intensified cell culture approaches can provide opportunities to increase cell density and volumetric productivity.
Protheragen supports the development and evaluation of intensified upstream processes, including:
Perfusion process development
N-1 perfusion development
High-cell-density culture development
Cell retention strategy evaluation
Perfusion rate optimization
Media exchange strategy optimization
Steady-state process evaluation
Intensified fed-batch process evaluation
Process productivity assessment
The appropriate culture mode is selected according to the characteristics of the molecule, cell line, manufacturing objectives, and process requirements.
Key Equipment & Technologies
Our upstream process development platform is supported by advanced bioreactor and cell culture analysis technologies for process optimization, monitoring, and scale-up.
Sartorius Bioreactor
Bioreactor Process Development
Controlled bioreactor systems for scalable cell culture process development
Applikon Bioreactor
Laboratory-Scale Bioreactor Systems
Flexible bioreactor platforms for cell culture optimization and process evaluation
Nova BioProfile
Multi-Parameter Cell Culture Analysis
Real-time monitoring of key metabolites and cell culture parameters
Cedex Bio Analyzer
Automated Bioprocess Analysis
Comprehensive analysis of cell culture performance and metabolic profiles
ABL9 Blood Gas Analyzer
Blood Gas & Metabolite Analysis
Rapid monitoring of pH, gases, and metabolic conditions during cell culture
Typical Upstream Process Development Workflow
Protheragen can organize upstream process development into a structured workflow:
Development Stage
Key Activities
Primary Outputs
Initial Assessment
Cell line and process review
Development strategy
Media Screening
Basal and feed media evaluation
Candidate media
Cell Culture Optimization
Temperature, pH, DO, inoculation and culture conditions
Optimized culture conditions
Feeding Strategy
Feed composition, timing and rate
Feeding strategy
Bioreactor Development
Bioreactor operating parameter optimization
Bioreactor process
Process Optimization
Parameter interaction and productivity studies
Optimized process
Quality Assessment
Process impact on product quality
Quality-oriented process conditions
Scale-Up
Bioreactor scale-up and verification
Scalable process
Process Transfer
Documentation and transfer support
Manufacturing-ready process
Key Performance Indicators
Depending on the development stage and product type, upstream process performance may be evaluated using multiple indicators rather than a single productivity metric.
Key indicators include:
Viable cell density (VCD)
Cell viability
Specific productivity
Product titer
Volumetric productivity
Cell growth rate
Nutrient consumption
Lactate and ammonia accumulation
Culture duration
Harvest yield
Process consistency
Product quality attributes
The selection of performance indicators is tailored to the molecule, cell line, process mode, and development objectives.
Why Process Optimization Matters
An optimized upstream process can contribute to:
Improved cell growth and viability
Increased product expression and titer
More consistent culture performance
Better control of cell metabolism
Improved understanding of process–quality relationships
Reduced process variability
More efficient scale-up
Improved manufacturing readiness
Importantly, the objective of upstream development is not simply to obtain the highest possible titer. A commercially viable process needs to demonstrate an appropriate balance between productivity, product quality, process robustness, scalability, and manufacturing practicality.
Why Choose Protheragen
Protheragen provides integrated upstream process development support covering cell culture optimization, media and feed strategy development, bioreactor process development, process parameter optimization, and scale-up support. Our development approach considers both process performance and product quality to help establish practical and reproducible upstream processes for biologics manufacturing.
Integrated Upstream Development Capabilities
Our upstream development services cover key stages from cell culture condition evaluation and media optimization to bioreactor development, process optimization, and scale-up. This integrated approach helps maintain continuity throughout the development process.
Product Quality-Oriented Process Development
Upstream process conditions can influence important product quality attributes. Protheragen evaluates process performance together with relevant quality considerations to support the development of process conditions that balance productivity, consistency, and product quality.
Flexible Cell Culture Strategies
Depending on the characteristics of the cell line and biologic product, development strategies can be adapted to different culture modes, including fed-batch and perfusion processes. Media composition, feeding strategies, culture conditions, and bioreactor parameters can be evaluated according to specific project requirements.
Process Optimization and Scale-Up Support
Process parameters are systematically evaluated to identify suitable operating conditions and improve process robustness. Scale-up considerations such as mixing, oxygen transfer, aeration, and feeding strategies are incorporated into development to facilitate the transition from laboratory-scale studies to larger bioreactor systems.
Cross-Functional CDMO Support
Upstream process development is closely connected with cell line development, downstream processing, analytical development, process characterization, and manufacturing. Protheragen's integrated CDMO capabilities allow upstream development activities to be coordinated with subsequent development and manufacturing stages, supporting a more continuous biologics development pathway.
Development Focused on Process Consistency
Rather than focusing solely on increasing product titer, Protheragen considers cell growth, viability, productivity, process stability, product quality, scalability, and reproducibility when developing upstream processes. This balanced approach supports the establishment of robust processes suitable for further characterization and manufacturing.
Featured Case Studies
Complex antibody molecules often require customized cell line engineering approaches to achieve balanced expression, productivity, and stability. Our platform integrates expression optimization, monoclonal screening, and early process evaluation to accelerate the development of reliable production cell lines.
Glycosylation Profile Optimization
Customized media and cell culture process optimization achieved a glycosylation profile highly consistent with the reference product.
A well-controlled upstream process provides the foundation for consistent and scalable biologics production. By integrating cell culture optimization, media and feeding strategy development, bioreactor process optimization, product quality considerations, and scale-up support, Protheragen helps establish upstream processes aligned with the requirements of downstream development and manufacturing. From early process development to manufacturing preparation, our biologics upstream process development services support the advancement of biologic candidates toward efficient, reproducible, and scalable production. Contact us to discuss your biologics upstream process development requirements and development goals.
Reference
Liang K, et al. "Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies" Front. Bioeng. Biotechnol. 2023, 11:1112349.
Fig.1 Schematic diagram of the CHO perfusion culture for the production of anti-PD-1 monoclonal antibody (mAb). (Liang K, et al., 2023)
